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Background: Few trials have compared estimates of change in physical activity (PA) levels using51
self-reported and objective PA measures when evaluating trial outcomes. The PACE-UP trial offered52
the opportunity to assess this, using the self-administered International Physical Activity53
Questionnaire (IPAQ) and waist-worn accelerometry.54
Methods: The PACE-UP trial (N=1023) compared usual care (n=338) with two pedometer-based55
walking interventions, by post (n=339) or with nurse support (n=346). Participants wore an56
accelerometer at baseline and 12 months and completed IPAQ for the same 7-day periods. Main57
outcomes were weekly minutes, all in ≥10 minute bouts as per UK PA guidelines of: i) accelerometer 58
moderate-to-vigorous PA (Acc-MVPA) ii) IPAQ moderate+vigorous PA (IPAQ-MVPA) and iii)59
IPAQ walking (IPAQ-Walk). For each outcome, 12 month values were regressed on baseline to60
estimate change.61
Results: Analyses were restricted to 655 (64%) participants who provided data on all outcomes at62
baseline and 12 months. Both intervention groups significantly increased their accelerometry MVPA63
minutes/week compared with control: postal group 42 (95% CI 22, 61), nurse group 43 (95% CI 24,64
63). IPAQ-Walk minutes/week also increased: postal 57 (95% CI 2, 112), nurse 43 (95% CI -11, 97)65
but IPAQ-MVPA minutes/week showed non-significant decreases: postal -11 (95% CI -65, 42), nurse66
-34 (95% CI -87, 19).67
Conclusions: Our results demonstrate the necessity of using a questionnaire focussing on the68
activities being altered, as with IPAQ-Walk questions. Even then, the change in PA was estimated69
with far less precision than with accelerometry. Accelerometry is preferred to self-report70
measurement, minimising bias and improving precision when assessing effects of a walking71
intervention.72
73








Adults who participate in regular physical activity (PA) and remain fit and active into later life have81
fewer chronic health conditions, and are better able to maintain a healthy weight [1]. WHO, UK and82
US aerobic PA guidelines for adults recommend at least 150 minutes weekly of moderate-to-83
vigorous-physical-activity (MVPA) in bouts of at least 10 minutes, or 75 minutes of vigorous PA, or84
a combination. Brisk walking (3 miles/hr or 5 km/hr) counts as MVPA[2] and for most people85
approximates to 1000 steps in 10 minutes[3].86
87
Self-report questionnaires are a quick, easy way to assess PA. Population surveys such as the Health88
Survey for England (HSE)[4] and Sport England’s “Active Lives Survey”[5] use self-completed89
questionnaires and report estimates that around 60% of participants aged 16+ meet PA guidelines.90
However, individuals often over-estimate their PA, particularly walking, on questionnaires compared91
with accelerometry measures of MVPA[6-8]. Self-report questionnaires can thus lead to inflated92
estimates of “active” individuals[9].93
94
The International Physical Activity Questionnaire (IPAQ) short form[10] assesses 7-day recall of PA95
in ≥10 minute bouts based on intensity (separating vigorous, moderate and walking activity) and 96
duration (days per week and minutes per day). The shorter General Practice Physical Activity97
Questionnaire (GPPAQ)[11] does not provide a continuous measure of PA, but categorises98
individuals as active or not. GPPAQ is used in the UK National Health Service (NHS) primary care99
cardiovascular health checks[12]. Individuals classified as less than “active” are assumed not to be100
meeting PA guidelines and are offered advice. In contrast, accelerometry is an objective PA measure,101
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providing information on step-counts and time spent in different PA intensities and is increasingly102
being used in cross-sectional studies to study PA[13, 14]. Although accelerometers e.g. Actigraph are103
not a gold standard for measuring PA, they have been shown to correlate well with doubly labelled104
water to measure activity energy expenditure[15]. For the Actigraph GT3X accelerometer, standard105
cut-points for accelerometer counts per minute (CPM) for different PA intensity categories have also106
been defined, thus leading to assessment of time spent in different PA intensities: light 101-1951107
CPM; moderate 1952-5724 CPM; vigorous ≥5725 CPM[16]. 108
109
Longitudinal studies and trials which examine PA changes over time need valid, reliable PA110
assessment methods. Both IPAQ-Short and accelerometry have been used separately to measure PA111
change over time,[17-20] but only a few small studies have used both and compared change in112
minutes of PA[21, 22]. Other studies have compared self-report PA minutes with either pedometer113
steps[23, 24] or accelerometry counts[25] which are not directly comparable. The PACE-UP trial114
offers the opportunity to directly compare change in PA minutes from accelerometry and IPAQ within115
a large trial dataset. This study had the following objectives: to compare the trial treatment effects at116
12 months (difference between intervention and control groups in the change in PA) using (i)117
accelerometry minutes of MVPA and IPAQ minutes of moderate+vigorous activity and walking; (ii)118
the percentage of “active” individuals classified by accelerometry, IPAQ and GPPAQ.119
120
METHODS121
Background to the PACE-UP study122
The PACE-UP study is a three-arm parallel groups randomised controlled trial comparing a 3-month123
pedometer-based walking intervention, delivered by post or with nurse support, to usual care[26].124
Ethical approval was given by the London Research Ethics Committee (Hampstead) (12L/LO/0219),125
trial registration ISRCTN 98538934. Adults aged 45-75 years from seven South-West London (UK)126
General Practices (family practices) who self-reported as inactive were invited to take part. Following127
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a baseline assessment to assess eligibility, 1023 participants gave informed written consent and were128
randomised into one of three groups: the Control group (n=338) received usual care; the Postal group129
(n=339) received a pedometer, a 12-week personalised walking plan including behaviour change130
techniques (e.g. goal setting, self-monitoring) designed to increase their walking and a step-count131
diary through the post; the Nurse group (n=346) received these and were additionally offered three132
individual practice nurse PA consultations. Randomisation was carried out at household level133
allowing couples to take part together. The main trial outcomes were changes in accelerometry134
measured average daily step-count and total weekly time in MVPA in ≥10 minute bouts between 135
baseline and 12 months. 956/1023 (93%) provided at least one day of accelerometry data at 12136
months, >90% provided at least 5 days wear. The postal and nurse groups both significantly increased137
their objective PA levels (step count and time in MVPA) compared with the control group, with no138
difference between intervention groups at 12 months[27].139
140
Participants wore a sealed accelerometer (GT3X, Actigraph LLC) over their hip for 7 consecutive141
days at baseline, prior to randomization, and 12 months post-randomization. They also completed the142
IPAQ Short form[10] and GPPAQ[11], both designed for self-completion, for the same 7-day periods143
as they wore the accelerometer. Actilife software (v 6.6.0) was used to extract and reduce the144
Actigraph data, ignoring runs of ≥60 minutes of zero counts[26], to provide daily steps counts and 145
time spent in ≥10 minute bouts of MVPA (≥1952 counts per minute, equivalent to ≥3 Metabolic 146
Equivalents (METs))[16]. When assessing ≥10 minute bout, the default “drop time” of 2 minutes was 147
used, which allows for a 2 minute interruption in bout activity. At baseline, all participants provided148
≥5 days of ≥540 minutes accelerometer wear-time. To limit attrition bias, those providing ≥1 day of 149
≥540 minutes accelerometer wear time at 12 months were included in analyses. IPAQ questions focus 150
on time spent being physically active in the previous seven days in at least 10 minute bouts, including151
PA at work, home, travelling and leisure. For each of vigorous and moderate PA and walking, there152
are questions on the number of days and the duration on each of these days. GPPAQ questions ask153
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about PA at work and the type and weekly duration of leisure PA (physical exercise/sport, cycling,154
walking, housework/childcare and gardening/DIY). Duration categories are None, <1 hour, 1-3 hours,155
≥3 hours.  156
157
Study outcomes158
Accelerometry: The main accelerometry outcome was total weekly minutes of MVPA in ≥10 minute 159
bouts; a secondary outcome was total weekly minutes of MVPA, including MVPA in <10 minute160
bouts. Binary variables were generated for each MVPA outcome to indicate 150 minutes of activity.161
IPAQ: Total weekly minutes spent in each of vigorous PA, moderate PA and walking were calculated,162
capped at a maximum of 3 hours/day or 21 hours/week, as recommended by the IPAQ coding163
guidelines[28]. Two self-report PA measures were derived: total weekly minutes of vigorous +164
moderate PA in bouts of ≥10 minutes, excluding walking (IPAQ-MVPA) and total weekly minutes 165
of walking in bouts of ≥10 minutes (IPAQ-Walk). We also report an additional outcome, IPAQ-Total 166
(IPAQ-MVPA + IPAQ-Walk), conceptually the same construct as accelerometry MVPA in ≥10 167
minute bouts. Binary variables were generated for each of these to indicate 150 minutes or more per168
week of activity.169
GPPAQ: The GPPAQ Physical Activity Index is a 4-level index ranging from “Inactive” through to170
“Active”. “Active” individuals are achieving ≥3 hours (180 minutes) of MVPA per week including 171
work PA and leisure PA from physical exercise and cycling, but not including PA from walking,172
housework/childcare or gardening. We defined a binary outcome, GPPAQ, to identify those173
individuals classified as “Active” by the GPPAQ score. However, adults who are retired or not174
working and who do no sport or cycling can never be classified as active, although they may achieve175
MVPA guidelines through walking. Thus, a modified index, GPPAQ-Walk, was also derived, where176
those who reported walking briskly for at least 3 hours per week were classified as “active”. . Previous177
analysis of GPPAQ showed this modified index had improved sensitivity at identifying active178




Analyses were carried out using Stata 14[30]. Multi-level regression models estimated treatment182
effects for accelerometer, IPAQ and GPPAQ outcomes. The 12-month outcome was regressed on183
baseline value, treatment group, age, gender, practice and month of baseline accelerometry as fixed184
effects and household as a random effect in the multi-level model. (i) Linear regression was used for185
weekly minutes of accelerometer MVPA, IPAQ-MVPA, IPAQ-Walk and IPAQ-Total; (ii) logistic186
regression was used for the binary variables “active” from accelerometry, IPAQ and GPPAQ. The187
distributions of change in PA for the four continuous outcomes were reasonably normally distributed,188
as were the distributions of residuals from the models, allowing this method of analysis. Analyses189
were restricted to those with complete data for all outcomes being compared: 833 at baseline and 655190
for the longitudinal regression models. This ensured direct comparisons of the same group of191
participants for each outcome. Sensitivity analyses used ≥180 minutes of accelerometer MVPA and 192
IPAQ outcomes, as the GPPAQ outcome is based on ≥180 minutes per week. 193
194
RESULTS195
At baseline, accelerometry data were available on all participants and 989 (97%) returned IPAQ and196
GPPAQ questionnaires. At 12 months, 956 (93%) participants provided at least one day of197
accelerometry and 942 (92%) returned IPAQ and GPPAQ questionnaires. However, incomplete198
answers on IPAQ and GPPAQ questions reduced the sample size to 833 at baseline and to 655 for199
analyses of changes between baseline and 12 months. Study groups were balanced at baseline for the200
833 with complete data with respect to age, gender, ethnicity and different health measures (Table 1).201
One third of participants were male and two thirds were overweight or obese (Body Mass Index202
≥25kg/m2). Mean weekly minutes of accelerometer-MVPA were 317 (sd 151) for total MVPA and203
98 (sd 103) for MVPA in ≥10 minute bouts. Self-reported mean weekly minutes were 174 (sd 279) 204
for IPAQ-MVPA, 315 (sd 310) for IPAQ-Walk, similar to total accelerometry MVPA and 489 (sd205
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453) for IPAQ-Total. Accelerometry data classified 23% of participants at baseline as “Active” i.e.206
achieving ≥150 minutes of MVPA per week in ≥10 minute bouts (Table 1). In contrast, 35%, 66% 207
and 84% of participants self-reported ≥150 minutes per week of IPAQ-MVPA, IPAQ-Walk and 208
IPAQ-Total respectively. GPPAQ classified 12% of participants as active which increased to 28%209
when walking was included.210
211
i) Comparison of estimated treatment effects using minutes of physical activity212
Both intervention groups showed statistically significant increases in accelerometer-MVPA, both in213
bouts and total, compared with controls. Increases in accelerometer-MVPA bouts: postal group 42214
minutes/week (95% CI 22 to 61), nurse group 43 (95% CI 24 to 63) (Table 2 and Figure 1a); increases215
for total accelerometry MVPA were almost identical to accelerometer-MVPA in bouts but with wider216
confidence intervals (Table 2 and Figure 1). Repeating the analysis using the IPAQ outcomes, IPAQ-217
Walk showed positive increases, similar in magnitude to accelerometer-MVPA in the nurse group,218
but with wider confidence intervals indicating less precision: postal group 57 minutes (95% CI 2 to219
112), nurse group 43 (95% CI -11 to 97). IPAQ-MVPA showed non-significant decreases and IPAQ-220
Total showed non-significant increases. The distribution of residuals from the regression models were221
normally distributed for MVPA in bouts[27] and IPAQ outcomes (data not shown).222
223
ii) Comparison of estimated treatment effects using the binary variable “active”224
Similar patterns were found for the binary variable “active” for the different outcomes. Odds ratios225
(ORs) for being “active” at 12 months (achieving ≥150 weekly minutes of MVPA in ≥10 minute 226
bouts) conditional on baseline “active” status were statistically significant for accelerometry-MVPA:227
postal group 3.7 (95% CI 1.8 to 7.5) and nurse group 2.9 (95% CI 1.5 to 5.7) (Table 3). IPAQ-Walk228
showed statistically significant OR for the postal group, 2.1 (95% CI 1.2 to 4.0) and borderline for229
the nurse group, 1.7 (95% CI 1.0 to 3.0). Results were inconclusive for IPAQ-MVPA and IPAQ-230
Total had increased ORs for both intervention groups, but only statistically significant for the nurse231
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group ORs for the two GPPAQ outcomes were close to 1.0 suggesting that GPPAQ was unable to232
identify changes in the proportion classified as “active” (Table 3). Sensitivity analyses using ≥180 233
minutes of the accelerometer and IPAQ outcomes gave similar results.234
235
DISCUSSION236
The PACE-UP study was a walking intervention designed to increase individuals’ PA through a 3-237
month programme, in particular MVPA in ≥10 minute bouts in line with current UK, WHO and US 238
PA guidelines[31-33]. We found statistically significant increases between baseline and 12 months239
in accelerometer measured MVPA in ≥10 minute bouts for both intervention groups compared with 240
control. IPAQ-Walk showed a significant increase in the postal group and a non-significant increase241
in the nurse group compared with control, but with less precision than with accelerometry.242
IPAQ-MVPA showed non-significant decreases and IPAQ-Total non-significant increases in243
intervention groups compared with controls. When considering the proportion of “active” individuals,244
only accelerometry showed statistically significant increases for both intervention groups versus245
controls. IPAQ-Walk and IPAQ-Total showed statistically significant increases for one intervention246
group compared with controls (postal for IPAQ-Walk and nurse for IPAQ-Total), but borderline247
effects for the other intervention group compared with controls. Neither IPAQ-MVPA nor GPPAQ248
identified any change in the proportions categorised as “active” in intervention versus control groups.249
Therefore, in terms of overall construct validity for assessing change in walking in a walking250
intervention study, accelerometry has the greatest validity, followed by IPAQ-Walk. The other251
measures have considerable disadvantages: IPAQ-MVPA and GPPAQ have very poor construct252
validity; IPAQ-Total is measured with substantial imprecision and is unsuitable for assessing a253
walking intervention as it includes IPAQ-MVPA.254
255
Our study had several strengths. It was based on a large population-based sample of adults from seven256
south-west London (UK) general practices (family practices), predominantly classified as inactive at257
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baseline. Accelerometry is an objective PA measure and measures walking accurately. We used258
standard cut-points to define the different intensities of accelerometry activity and were thus able to259
identify those bouts of walking which can be classified as MVPA. The main PACE-UP analysis[27]260
showed that the increase in weekly steps in intervention groups relative to control group was261
equivalent to the increase in weekly minutes of MVPA and this was all in ≥10 minute bouts, thus 262
demonstrating the effectiveness of the PACE-UP walking intervention. The two self-completed263
questionnaires, IPAQ and GPPAQ, are standard questionnaires used to assess PA, and were264
completed for the same seven days as for accelerometry, thus providing directly comparable estimates265
of effect. The study achieved 93% accelerometry follow-up at 12 months, >90% of these with ≥5 266
days wear-time. Total weekly minutes of MVPA and total weekly minutes of walking (not including267
MVPA) were easy to extract from IPAQ and provided a direct comparison with minutes of268
accelerometer-MVPA. The increases in IPAQ-Walk minutes are similar to those for accelerometer-269
MVPA suggesting that IPAQ can identify changes in walking minutes, although the wider confidence270
intervals show the loss of precision from using IPAQ. At baseline, average IPAQ-Walk minutes were271
similar to average total accelerometer-MVPA minutes rather than accelerometer-MVPA in ≥10 272
minute bouts. This is perhaps unsurprising, as the IPAQ walking questions ask for number of days273
walking and duration on each day, and people may find it easier to report walking minutes as a274
rounded number e.g. 30 or 45 minutes per day and which may include relative short walks of <10275
minutes. GPPAQ is commonly used in UK general practice to assess an individual’s PA. However,276
it can underestimate PA amongst those not working or those whose main PA is walking, and this277
study provided a further opportunity to evaluate our modified GPPAQ–Walk index[29]. We were278
also able to estimate how well GPPAQ could identify individuals moving from “not active” to279
“active” (assumed to be achieving PA guidelines). Finally, our method of analysis, regressing280
outcome at 12 months on baseline values focusses on individual changes in activity while allowing281
for regression to the mean. Cross-sectionally, the distributions of accelerometer-MVPA and IPAQ282
measures are highly skewed leading many to present medians and interquartile ranges of activity at283
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different time points. However, change in activity is usually symmetric and reasonably normally284
distributed, which our approach exploits. We were thus able to present mean changes in activity and285
associated confidence intervals for both accelerometry and questionnaire measures, thus allowing for286
a more informative comparison.287
288
The study also had some important limitations. All of the PA measures (accelerometry, IPAQ and289
GPPAQ) only measured PA levels for 7 days and it may be that participants were more likely to be290
active or report being active in the week that their PA was being assessed, rather than at other times.291
However, any such tendency would potentially affect all of the PA measures and would be true for292
control participants as well as for those in the intervention group. IPAQ is difficult to complete and293
thus unreliable if an individual’s PA varies by day across the week. Although we had high return rates294
at baseline and 12 months for the IPAQ and GPPAQ, 97% and 92% respectively, each IPAQ outcome295
at baseline and 12 months had 20-25% missing or incomplete answers. Participants’ comments on296
the questionnaires described their confusion over how to interpret and answer the questions and many297
questions were left blank. This reduced our sample size to 655 for comparisons with accelerometry298
although this is still large compared with other studies[21-23]. The proportions of missing data were299
similar across the three groups, but those with missing IPAQ data had lower mean300
accelerometry-MVPA at baseline and 12 months than those with complete data. The accelerometry301
effect sizes reported here (42-43 minutes) are also larger than for the full cohort (33-35 minutes)[27].302
The limited options on GPPAQ for duration of PA, led to using ≥3 hours (180 minutes) for GPPAQ 303
“active” whereas the PA guidelines are ≥150 minutes. However, ORs from sensitivity analyses using 304
≥180 minutes for accelerometry and IPAQ outcomes were similar to those using ≥150 minutes. 305
Although neither of our methods of measuring PA are considered a gold-standard, accelerometry has306
the advantage of providing an objective time-stamped record of PA that does not rely on recall. It has307
been validated as a measure of activity energy expenditure using doubly labelled water[15] and we308
used standard cut-points in counts per minute to define MVPA.[16] Our findings that309
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accelerometer-MVPA and IPAQ-Walk provide similar estimates of change clearly support results310
from the PACE-UP intervention which is aimed at increasing walking, but it is unknown if these311
findings would be generalisable to other PA interventions.312
313
Participants in the postal and nurse intervention groups were encouraged to increase their MVPA314
through walking and the nurse group in particular were taught to recognise and classify different PA315
intensities – vigorous, moderate, light, and sedentary. Thus they may have been more likely to316
accurately report their PA on IPAQ at follow-up i.e. with less over-estimation of their PA levels,317
which could explain the non-significant decreases in the treatment groups for IPAQ-MVPA from the318
modelling.319
320
Comparison with other studies321
Our baseline data agree with other studies that individuals tend to over-estimate their PA on self-322
report questionnaires compared with objective accelerometry, both time spent being physically323
active[6] and proportions achieving PA guidelines[7]. Studies which have found better324
correspondence between IPAQ and accelerometry cross-sectionally[34] have used total325
accelerometer MVPA rather than MVPA in ≥10 minute bouts and a similar pattern is seen in our data 326
where baseline total accelerometer-MVPA minutes are similar to IPAQ-Walk minutes. However,327
IPAQ questions ask about vigorous and moderate PA in ≥10 minute bouts and UK, WHO and US PA 328
guidelines are based on ≥150 minutes of MVPA per week in ≥10 minute bouts. In our trial, whilst 329
total accelerometry MVPA was much higher than accelerometry MVPA in ≥10 minute bouts, changes 330
in both measures were almost identical.331
332
To our knowledge, this is the largest population-based trial to make direct comparisons of333
accelerometry and self-report questionnaires to assess an individual’s change in minutes of PA after334
an intervention. All five studies we identified [21-25] which have attempted to compare longitudinal335
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changes in PA measured using IPAQ compared to objective measures have limitations. Three studies336
recruited less than 100 subjects[21-23]. One study was observational[21], one had no control337
group[22] and one was a weight loss intervention rather than PA intervention[24]. One study was338
comparing IPAQ with pedometer steps[23] and another with accelerometer counts[25] making direct339
comparison of minutes of physical activity between IPAQ and accelerometry difficult. Whilst our340
study compares measures using different constructs, we were able to compare time spent in MVPA341
and time spent walking, both in minutes per week. Three studies present distribution of PA measures342
at baseline and follow-up, but provided no estimate of the distribution of change[21, 24, 25] Our343
findings do agree with two of the small studies. Nicaise et al[22] followed up one group of women,344
but with no control group, and found median changes in IPAQ Walking minutes were similar to345
median changes in accelerometer MVPA minutes. Baker et al[23] compared IPAQ PA minutes with346
pedometer steps, and argue that the increase in step counts in the intervention group was comparable347
to the increase in leisure time walking reported on IPAQ, although they report mean differences for348
pedometer steps and median differences for IPAQ data.349
350
GPPAQ is used in UK primary care to help identify those not achieving PA guidelines during UK351
NHS Health Checks [12]. GPPAQ guidance recommends repeating it annually on those at increased352
cardiovascular risk [11], however our study suggests that it is poor at identifying those individuals353
who have increased their PA to current guideline levels. In addition, the binary nature of this outcome354
fails to recognise modest, but important, increases in PA made by inactive individuals. We have also355
confirmed our previous findings [29] that, compared with objective accelerometry, GPPAQ356
underestimates the proportion of “active” individuals and our modified index GPPAQ-Walk classifies357




We have demonstrated that neither GPPAQ nor IPAQ-MVPA provide a valid estimate of change in361
a walking intervention trial compared with accelerometry measures. Moreover, we have shown that362
although IPAQ-Walk produces an estimate of change comparable with that from accelerometry363
MVPA in ≥10 minute bouts, the IPAQ-Walk estimate had considerably less precision. Missing data 364
were also an issue with the self-report IPAQ. This has implications for future trials. Studies may need365
to use IPAQ to assess changes in walking if they are not able to use accelerometry. If this is the case,366
they should focus particularly on the walking questions and will need to be larger to be adequately367
powered, although they will still lack information on intensity of any changes that occur. In368
conclusion, accelerometry is preferred to self-report measures in assessing the effects of a walking369




MVPA: Moderate-to-vigorous physical activity374
IPAQ: International Physical Activity Questionnaire375
GPPAQ: General Practice Physical Activity Questionnaire376
NHS: UK National Health Service377
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Figure 1. Treatment effects and 95% confidence intervals for change in minutes of physical activity522


















n (%) n (%) n (%) n (%)
Age at randomisation
45-54 years 280 (34%) 87 (31%) 94 (35%) 99 (35%)
55-64 years 315 (38%) 111 (40%) 98 (36%) 106 (37%)
65-75 years 238 (29%) 81 (29%) 78 (29%) 79 (28%)
Sex: Male 304 (36%) 98 (35%) 104 (39%) 102 (36%)
Ethnicity
White 654 (81%) 212 (79%) 222 (85%) 220 (80%)
Black / African / Caribbean / Black British 77 (10%) 25 (9%) 21 (8%) 31 (11%)
Asian / Asian British 54 (7%) 21 (8%) 14 (5%) 19 (7%)
Other, incl mixed 19 (2%) 10 (4%) 4 (2%) 5 (2%)
General health: Very good or good 679 (83%) 223 (81%) 230 (88%) 226 (82%)
Chronic diseases
None 321 (39%) 109 (39%) 112 (42%) 100 (36%)
1-2 436 (53%) 153 (55%) 133 (50%) 150 (54%)
≥3 61 (7%) 14 (5%) 20 (8%) 27 (10%)
Self-reported pain: Yes 566 (69%) 185 (67%) 191 (72%) 190 (69%)
Limiting long-standing illness 174 (21%) 60 (22%) 55 (21%) 59 (21%)
Townsend Disability score
None (0) 491 (60%) 159 (58%) 158 (59%) 174 (62%)
Slight or some disability (1-6) 305 (37%) 103 (37%) 104 (39%) 98 (35%)
Appreciable or severe disability (7-18) 24 (3%) 13 (5%) 4 (2%) 7 (3%)
532
23
Physical characteristics n (%) n (%) n (%) n (%)
Overweight/obese: BMI≥25kg/m2 544 (65%) 184 (66%) 173 (64%) 187 (66%)
Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Fat mass (kg) 26 (11) 26 (10) 26 (11) 26 (11)
Accelerometry data Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Adjusted baseline step count per day 7550 (2670) 7528 (2685) 7480 (2583) 7638 (2744)
Total weekly mins MVPA in ≥10 min bouts 98 (103) 91 (100) 97 (94) 106 (113)
Total weekly mins MVPA 317 (151) 316 (152) 311 (145) 322 (154)
Daily wear time (minutes) 792 (79) 791 (73) 789 (79) 796 (84)
International Physical Activity Questionnaire (IPAQ)
IPAQ-MVPA: Weekly mins of moderate PA
+ vigorous PA in ≥10 min bouts 
174 (279) 194 (310) 159 (266) 167 (259)
IPAQ-Walk: Weekly minutes of walking in
≥10 min bouts 
315 (310) 323 (327) 316 (326) 307 (275)
IPAQ-Total: Weekly minutes of moderate
PA+vigorous PA+walking in >-10 min bouts
489 (453) 518 (501) 475 (457) 474 (395)
Proportions of "active" individuals 1 n (%) n (%) n (%) n (%)
Accelerometry
150 weekly mins MVPA in ≥10 min bouts 190 (23%) 57 (21%) 58 (22%) 75 (27%)
International Physical Activity Questionnaire (IPAQ)
150 weekly mins of IPAQ-MVPA 286 (35%) 99 (36%) 86 (32%) 101 (36%)
150 weekly mins of IPAQ-Walk 540 (66%) 176 (64%) 173 (65%) 191 (68%)
150 weekly mins of IPAQ-Total 690 (84%) 227 (82%) 226 (85%) 237 (84%)
General Practice Physical Activity Questionnaire (GPPAQ)
GPPAQ: "Active" ≥180 mins PA per week 101 (12%) 38 (14%) 33 (12%) 30 (11%)
24
GPPAQ-Walk: "Active" ≥180 mins PA per 
week including walking at brisk/fast pace
229 (28%) 82 (30%) 71 (27%) 76 (27%)
533
Footnotes534
1 Proportions of "active" individuals are based on 276, 265 and 281 participants in Control, Postal and Nurse535
groups respectively536
25
Table 2. Physical activity outcomes (total weekly minutes) at baseline and 12 months for accelerometry and IPAQ 537
Group summary data Treatment effects
Control group (n=231) Postal group (n=207) Nurse group (n=217) Postal vs Control Nurse vs Control
Baseline 12 months Baseline 12 months Baseline 12 months Effect p-value Effect p-value
Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd) (95% CI) (95% CI)
Accelerometry outcomes





MVPA in ≥10 min 
bouts (weekly minutes)





































Table 3. Physical activity outcomes (“active”) at baseline and 12 months for accelerometry, IPAQ and GPPAQ539
Group summary data Treatment effects
Control group (n=228) Postal group (n=205) Nurse group (n=213) Postal vs Control Nurse vs Control
Baseline 12 months Baseline 12 months Baseline 12 months OR p-value OR p-value
N (%) N (%) N (%) N (%) N (%) N (%) (95% CI) (95% CI)
Accelerometry




























PA Index: Active ≥180 mins 
PA per week





PA Index incl walking:
Active ≥180 mins PA per 
week including walking at
brisk/fast pace
66 (29%) 77 (34%) 62 (30%) 74 (36%) 59 (28%) 70 (33%) 1.1
(0.7, 1.9)
0.66 1.0
(0.6, 1.8)
0.89
540
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